Novartis Investigative Site

Tunis 1008

0 studies enrolling now · 7 studies all time

What they study most

Acute Heart Failure, Behcet Disease, Breast Neoplasms, Chronic Spontaneous Urticaria, Purpura, Thrombocytopaenic, Idiopathic, Transfusion-dependent Anemia, Transfusional Iron Overload in β-thalassemia

Studies at this site

• Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload — Completed
• Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab — Stopped early
• Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer — Completed
• Global Non-interventional Heart Failure Disease Registry — Stopped early
• EXTEND (Eltrombopag Extended Dosing Study) — Completed
• Phase III Study in Refractory Behcet's Disease — Completed
• An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload — Completed